MINIMAL RESIDUAL DISEASE IN THE CLINICAL PRACTICE OF MULTIPLE MYELOMA PATIENTS

被引：0

作者：

Cedena, M. T. ^{[1
]}

Puig, N. ^{[2
]}

Paiva, B. ^{[3
]}

Perez, A. ^{[4
]}

De Arriba, F. ^{[5
]}

Cuellar, C. ^{[1
]}

Blanchard, M. J. ^{[6
]}

Martinez-Chamorro, C. ^{[7
]}

Casanova, M. ^{[8
]}

Sirvent, M. ^{[9
]}

Rodriguez-Otero, P. ^{[3
]}

Martinez-Lopez, J. ^{[1
]}

Mateos, M., V ^{[2
]}

San Miguel, J. F. ^{[3
]}

Lahuerta, J. J. ^{[1
]}

机构：

[1] Hosp 12 Octubre, Madrid, Spain

[2] Hosp Univ Salamanca, Salamanca, Spain

[3] Clin Univ Navarra, Pamplona, Spain

[4] Hosp Son Espases, Palma De Mallorca, Illes Balears, Spain

[5] Hosp JM Morales Meseguer, Murcia, Spain

[6] Hosp Ramon & Cajal, Madrid, Spain

[7] Hosp Quirosalud Madrid, Madrid, Spain

[8] Complejo Hosp Costa del Sol, Malaga, Spain

[9] Hosp Donostia, San Sebastian, Spain

来源：

HAEMATOLOGICA | 2019年 / 104卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

CO-013

引用

页码：15 / 15

页数：1

共 50 条

[31] Drug resistance and minimal residual disease in multiple myeloma
Gozzetti, Alessandro
Ciofini, Sara
Sicuranza, Anna
Pacelli, Paola
Raspadori, Donatella
Cencini, Emanuele
Tocci, Dania
Bocchia, Monica
CANCER DRUG RESISTANCE, 2022, 5 (01) : 171 - 183
[32] Recommendations for quantitation of minimal residual disease in multiple myeloma
Rasmussen, T
Johnsen, HE
BONE MARROW TRANSPLANTATION, 2002, 29 : S128 - S128
[33] Targeting minimal residual disease in myeloma patients
Kroeger, N.
ONKOLOGIE, 2010, 33 : 10 - 11
[34] Molecular Monitoring of Minimal Residual Disease in the Peripheral Blood of Patients with Multiple Myeloma
Korthals, Mark
Sehnke, Nina
Kronenwett, Ralf
Schroeder, Thomas
Strapatsas, Tobias
Kobbe, Guido
Haas, Rainer
Fenk, Roland
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2013, 19 (07) : 1109 - 1115
[35] Minimal residual disease monitoring and immune profiling in multiple myeloma in elderly patients
Paiva, Bruno
Cedena, Maria-Teresa
Puig, Noemi
Arana, Paula
Vidriales, Maria-Belen
Cordon, Lourdes
Flores-Montero, Juan
Gutierrez, Norma C.
Martin-Ramos, Maria-Luisa
Martinez-Lopez, Joaquin
Ocio, Enrique M.
Hernandez, Miguel T.
Teruel, Ana-Isabel
Rosinol, Laura
Echeveste, Maria-Asuncion
Martinez, Rafael
Gironella, Mercedes
Oriol, Albert
Cabrera, Carmen
Martin, Jesus
Bargay, Joan
Encinas, Cristina
Gonzalez, Yolanda
Van Dongen, Jacques J. M.
Orfao, Alberto
Blade, Joan
Mateos, Maria-Victoria
Jose Lahuerta, Juan
San Miguel, Jesus F.
BLOOD, 2016, 127 (25) : 3165 - 3174
[36] Functional and psychological impact of minimal residual disease assessment on patients with multiple myeloma
Correia, Nuno
Dowling, Emma
Popat, Rakesh
Rabin, Neil
Kyriakou, Chara
Sive, Jonathan
Yong, Kwee
Wechalekar, Ashutosh
BRITISH JOURNAL OF HAEMATOLOGY, 2023,
[37] Controversies in the Assessment of Minimal Residual Disease in Multiple Myeloma: Clinical Significance of Minimal Residual Disease Negativity Using Highly Sensitive Techniques
Noa Biran
Scott Ely
Ajai Chari
Current Hematologic Malignancy Reports, 2014, 9 : 368 - 378
[38] Controversies in the Assessment of Minimal Residual Disease in Multiple Myeloma: Clinical Significance of Minimal Residual Disease Negativity Using Highly Sensitive Techniques
Biran, Noa
Ely, Scott
Chari, Ajai
CURRENT HEMATOLOGIC MALIGNANCY REPORTS, 2014, 9 (04) : 368 - 378
[39] Minimal Residual Disease in Multiple Myeloma-Current Approaches and Future Clinical Implications
Akhlaghi, Theresia
Firestone, Ross
Hultcrantz, Malin
HEMATO, 2022, 3 (03): : 454 - 465
[40] Clinical implications of loss of bone marrow minimal residual disease negativity in multiple myeloma
Mohan, Meera
Kendrick, Samantha
Szabo, Aniko
Yarlagadda, Naveen
Atwal, Dinesh
Pandey, Yadav
Roy, Arya
Parikh, Richa
Lopez, James
Thanendrarajan, Sharmilan
Schinke, Carolina
Alapat, Daisy
Sawyer, Jeffrey
Tian, Erming
Tricot, Guido
van Rhee, Frits
Zangari, Maurizio
BLOOD ADVANCES, 2022, 6 (03) : 808 - 817

← 1 2 3 4 5 →